» Authors » Kirill I Kirsanov

Kirill I Kirsanov

Explore the profile of Kirill I Kirsanov including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 114
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fetisov T, Menyailo M, Ikonnikov A, Khozyainova A, Tararykova A, Kopantseva E, et al.
J Clin Med . 2024 Dec; 13(23). PMID: 39685635
Undifferentiated pleomorphic sarcoma (UPS) is a highly malignant mesenchymal tumor that ranks as one of the most common types of soft tissue sarcoma. Even though chemotherapy increases the 5-year survival...
2.
Lesovaya E, Fetisov T, Bokhyan B, Maksimova V, Kulikov E, Belitsky G, et al.
Cells . 2024 Oct; 13(20. PMID: 39451213
Synovial sarcoma (SS) is one of the most common types of pediatric soft tissue sarcoma (STS) being far less frequent in adults. This STS type is characterized by one specific...
3.
Zhidkova E, Tilova L, Fetisov T, Kirsanov K, Kulikov E, Enikeev A, et al.
Int J Mol Sci . 2024 Aug; 25(16). PMID: 39201590
Glucocorticoids (GCs) are widely used for treating hematological malignancies despite their multiple adverse effects. The biological response to GCs relies on glucocorticoid receptor (GR) transrepression (TR) that mediates the anticancer...
4.
Scherbakov A, Sorokin D, Razuvaeva V, Shchegolev Y, Andreeva O, Salnikova D, et al.
Biomed Rep . 2024 Feb; 20(3):42. PMID: 38343657
Combining chemotherapy and hormone therapy is a prevalent approach in breast cancer treatment. While the cytotoxic impact of numerous chemotherapy drugs stems from DNA damage, the exact role of these...
5.
Sokol M, Beganovskaya V, Mollaeva M, Yabbarov N, Chirkina M, Belykh D, et al.
Pharmaceutics . 2024 Jan; 16(1). PMID: 38258135
In this study, we described physico-chemical properties of novel nanoformulation of photosensitizer-pyropheophorbide α 17-diethylene glycol ester (XL) (chlorophyll α derivative), revealing insights into antitumor activity and maintaining quality, meeting the...
6.
Lesovaya E, Fetisov T, Bokhyan B, Maksimova V, Kulikov E, Belitsky G, et al.
Cancers (Basel) . 2024 Jan; 16(2). PMID: 38254762
Liposarcoma (LPS) is one of the most common adult soft-tissue sarcomas (STS), characterized by a high diversity of histopathological features as well as to a lesser extent by a spectrum...
7.
Dodonova S, Zhidkova E, Kryukov A, Valiev T, Kirsanov K, Kulikov E, et al.
Int J Mol Sci . 2023 Dec; 24(24). PMID: 38139366
This review is focused on synephrine, the principal phytochemical found in bitter orange and other medicinal plants and widely used as a dietary supplement for weight loss/body fat reduction. We...
8.
Fetisov T, Khazanova S, Shtompel P, Trapeznikova E, Zinovieva V, Marshall V, et al.
Int J Mol Sci . 2023 Aug; 24(15). PMID: 37569668
Treatment of highly malignant soft tissue sarcomas (STSs) requires multicomponent therapy including surgery, radiotherapy, and chemotherapy. Despite the advancements in targeted cancer therapies, cytostatic drug combinations remain the gold standard...
9.
Fetisov T, Borunova A, Antipova A, Antoshina E, Trukhanova L, Gorkova T, et al.
Biomedicines . 2023 Jan; 11(1). PMID: 36672738
The anticancer activity of Curaxin CBL0137, a DNA-binding small molecule with chromatin remodulating effect, has been demonstrated in different cancers. Herein, a comparative evaluation of CBL0137 activity was performed in...
10.
Zhidkova E, Lylova E, Grigoreva D, Kirsanov K, Osipova A, Kulikov E, et al.
Int J Mol Sci . 2022 Sep; 23(17). PMID: 36077083
Regulated in Development and DNA Damage Response 1 (REDD1)/DNA Damage-Induced Transcript 4 (DDIT4) is an immediate early response gene activated by different stress conditions, including growth factor depletion, hypoxia, DNA...